A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers
Clinical trial NCT01290900 · COMPLETED
Trial details
- NCT number
- NCT01290900
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-05-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.